Lenharo; Mariana

1 story written by The Global Wire newsroom from reporting first published by Lenharo; Mariana. Full credit for the original reporting belongs to them.

Visit Lenharo; Mariana →

Stories credited to Lenharo; Mariana

Science3h agoSource: Lenharo; Mariana

Beyond Weight Loss: GLP-1 Drugs Evaluated for Addiction, Parkinson’s, and Depression

Clinical trials are expanding to evaluate whether GLP-1 receptor agonists can treat central nervous system disorders including addiction, depression, schizophrenia, and Parkinson's…